We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App





Diatron Exhibits Abacus 5 and Aquila Hematology Analyzers

By LabMedica International staff writers
Posted on 08 Feb 2017
Diatron, which develops, manufactures and markets hematology analyzers, and clinical chemistry analyzers, showcased its latest products, the Abacus 5 and Aquila hematology analyzers, at MEDLAB 2017, the world’s largest laboratory exhibition and congress in the Middle East.

One of the world’s top hematology analyzer manufacturers, the Hungarian company’s product range also includes hematology reagents, hematology control material, clinical chemistry analyzers, clinical chemistry reagents, and clinical chemistry controls.

At MEDLAB 2017, held at the Dubai International Convention & Exhibition Centre, UAE, from February 6-9, 2017, Diatron showcased the most advanced model in its range of hematology analyzers, the Abacus 5, which utilizes patented laser-based optical measurement technology developed by the company. More...
The Abacus 5 provides a complete 26 parameter report, including optical determinations of the 5-part WBC differential count. It offers open and closed tube sampling options and has a throughput of 60 samples per hour in either stat or autoloader mode. The Abacus 5 hematology analyzer is one of the smallest 5-part differential analyzers available in the market and requires minimal bench space, thus making it ideal for use in space-restricted environments such as clinics and small to medium laboratories.

Diatron also exhibited Aquila, a 3-part differential hematology analyzer that can be used in any testing location and application where high quality CBC results are desired. The Diatron Aquila provides 3-part differential hematology results using less than 20 μl of whole blood and can operate in a closed or open tube mode. The system has a throughput of up to 60 tests per hour, and its compact size and unique on board reagent pack means that it requires little work and storage space. The Diatron Aquila can easily be moved from testing site to testing site and has an optional battery pack to support mobile testing needs and/or un-reliable main power supply locations.


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
HAV Rapid Test
OnSite HAV IgG/IgM Rapid Test
New
Enterovirus Test
Quanty Enterovirus System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.